Skip to main contentSkip to navigation
Sirius Investors
Kronos Bio, Inc.

Kronos Bio, Inc.

KRON
NASDAQHealthcare

Kronos Bio, Inc. (KRON) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Kronos Bio, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2024
P/E Ratio
-0.66
Burn Risk
P/B Ratio
0.65
Strong
WeakModerateStrong
Earnings Yield
-1.51%
Yield Gap

Profitability Health

2024
Return on Equity
-98.29%
Weak
WeakModerateStrong
Operating Margin
-943.21%
Weak
WeakModerateStrong
Net Profit Margin
-874.08%
Weak
WeakModerateStrong

Growth Indicators

2024
Revenue Growth
56.62%
Strong
WeakModerateStrong
Net Income Growth
23.60%
Strong
WeakModerateStrong
EPS Growth
26.67%
Strong
WeakModerateStrong

Efficiency & Liquidity

2024
Current Ratio
7.54
Strong
WeakModerateStrong
Quick Ratio
7.54
Strong
WeakModerateStrong
Asset Turnover
0.08x
Weak
WeakModerateStrong
Inventory Turnover
-
No data

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2024
Free Cash Flow Yield
-114.67%
Weak
WeakModerateStrong
EV / Free Cash Flow
0.04x
Strong
WeakModerateStrong
Net Debt / EBITDA
0.97x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.927
Moderate
WeakModerateStrong
Return on Invested Capital
-80.16%
Weak
WeakModerateStrong
Cash Conversion Cycle
-206.00 days
Strong
WeakModerateStrong

Fortress screener guardrails

2/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for KRON.

View Financial Statements